期刊文献+

急性运动轴索型神经病的预后分析 被引量:1

Prognostic analysis of acute motor axonal ncuropathy
原文传递
导出
摘要 目的 研究吉兰-巴雷综合征(GBS)的临床特征,分析比较急性炎性脱髓鞘型多神经病(AIDP)和急性运动轴索型神经病(AMAN)的预后。方法分析卫生部北京医院神经科自2003年1月至2007年12月收治的50例GBS患者临床资料,根据电生理分型诊断标准将患者分为AIDP组(24例)与AMAN组(22例),不能分类4例,对出院时仍不能独立行走的患者至少随访6个月,分析比较两组患者的临床特征和预后。结果AIDP与AMAN两组患者的性别、年龄、颅神经受累情况、就诊及高峰时的病情评级、接受的治疗方法等比较差异无统计学意义(P〉0.05):治疗1个月时患者Hughes运动功能评级两组间比较差异无统计学意义(P〉0.05);而AMAN组患者快速恢复、缓慢恢复的比例(63%,18%)均高于AIDP组(33%,4%),差异均有统计学意义(P〈0.05)。结论AMAN患者临床上存在快速恢复与缓慢恢复两种情况;对AMAN患者应予积极免疫治疗,以获早期恢复和较好预后。 Objective To investigate the clinical features of Guillain-Barr6 syndrome (GBS) and clarify the long-term prognosis of acute inflammatory demyelinating polyneuropathy (AIDP) and acute motor axonal neuropathy (AMAN). Methods We conducted an analysis of the clinical data of 50 patients with GBS treated in our hospital between 2003 and 2007. According to the electrophysiological criteria, the cases were classified into AIDP (n=24) and AMAN cases (n=22), with 4 cases of unknown classification. The patients unable to walk upon discharge were followed up for more than 6 months, and the clinical features and prognosis of the two groups were compared. Results The age, gender, cranial nerve involvement, Hughes grade at the initial neurological examination and at the time of symptom peak did not differ significantly between the patients with AIDP and AMAN (P〉0.05), and most of the AMAN patients had a good recovery. The number of patients capable of walking at one month aider the onset was comparable between the two groups (/:'〉0.05). In AMAN group, the percentages of patients with slow recovery and those having rapid recovery were significantly higher than those in AIDP group (P〈0.05). Conclusion The clinical recovery of AMAN patients can be either rapid or prolonged, and rigorous immunotherapy should be administered to achieve early recovery and ensure more favorable outcomes of the patients.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第5期496-499,共4页 Chinese Journal of Neuromedicine
关键词 吉兰-巴雷综合征 急性运动轴索型神经病 急性炎性脱髓鞘型多神经病 Guillain-Barre syndrome Acute inflammatory demyelinating polyneuropathy Acute motoraxonal neuropathy
  • 相关文献

参考文献11

  • 1Griffin JW, Li CY, Ho TW, et al, Guillain-Barre' syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases[J]. Brain, 1995, 118(6): 577-595.
  • 2van der Meche FG, van Doom PA, Meulstee J, et al. Diagnosis and classification criteria for the Guillain-barre' syndrome[J]. Eur Neurol, 2001, 45(3): 133-139.
  • 3Hughes RA, Newsom-Davis JM, Perkin GD. Controlled trial of prednisolone in acute polyneuropathy [J]. Lancet, 1978, 2 (253): 750-753.
  • 4Hiraga A, Mori M, Ogawara K, et al. Recovery patterns and long term prognosis for axonal Guillain-Barre syndrome [J]. Neurol Neurosurg Psychiatry, 2005, 76(1): 719-722.
  • 5Kawabata S . Guillain-barre ' syndrome : epidemiology, pathophysiology and management[J]. Drugs, 2004, 64(6): 597-610.
  • 6Hughes RA, Raphael JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barre' syndrome [J]. Cochrane Database Syst Rev, 2006, 25(1): CD002063.
  • 7Hughes RA, Swan AV, van Koningsveld R, et al. Corticosteroids for Guillain-Barre' syndrome [J]. Cochrane Database Syst Rev, 2006, 19(2): CD001446.
  • 8Kuwabara S, Asahina M, Koga M, et al. Two patterns of clinical recovery in Guillain-Barre' syndrome with IgG anti-GM 1 antibody [J]. Neurology, 1998, 51(6): 1656-1660.
  • 9Chowdhury D, Arora A. Axonal Guillain-Barre syndrome: a critical review[J]. Acta Neurol Scand, 2001, 103(8): 267-277.
  • 10Ogawara K, Kuwabara S, Moil M, et al. Axonal Guillain-Barre' syndrome relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan [J]. Ann Neurol, 2000, 48 (2): 624-631.

同被引文献11

  • 1Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiologieal classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/ Sandoglobulin Guillain-Barre Syndrome Trial Group [ J ]. Ann Neurol, 1998, 44 (5) :780-788. DOI : 10. 1002/ana. 410440512.
  • 2Ho TW, Mishu B, Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glyeolipid antibodies [ J]. Brain, 1995, 118 ( Pt 3) : 597-605.
  • 3Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barre syndrome : relation to anti-ganglioside antibodies and Campylobaeter jejuni infection in Japan [J]. Ann Neurol, 2000, 48(4) :624-631.
  • 4A prospective study on the incidence and prognosis of Guillain- Barresyndrome in Emilia-Romagna region, Italy ( 1992-1993 ). Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology [J]. Neurology, 1997, 48 ( 1 ) :214-221.
  • 5Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barre syndromes [ J ]. Neurology, 1997, 48 ( 3 ) : 695- 700.
  • 6Kuwabara S, Ogawara K, Mizobuchi K, et al. Mechanisms of early and late recovery in acute motor axonal neuropathy [J]. Muscle Nerve, 2001, 24(2) :288-291.
  • 7Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlledtrial prednisolone in acute polyneuropathy[J]. Lancet, 1978, 2 (8093) :750-753.
  • 8Kuwabara S. Guillain-Barr6 syndrome : epidemiology, pathophysiology and management [ J ]. Drugs, 2004, 64 ( 6 ) : 597- 610.
  • 9Enders U, Karch H, Toyka KV, et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain- Barre syndrome and in other neuroimmunological disorders[J]. Ann Neurol, 1993, 34 (2): 136-144. DOI: 10. 1002/ana. 410340208.
  • 10Hughes RAC, Swan AV, van KR, et al. Corticosteroids for Guillain-Barre' syndrome. Cochrane Database Syst Rev, 2006, CD001446.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部